Home » Archive
Chinese Journal of Digestive SurgerySeptember 2018,Vol.17,No.9Editorials

Research progress of mesenchymal stromal cells therapy for patients with inflammatory bowel disease

Read More£º
¡¾Clicks£º22¡¿¡¾Download£º10¡¿
¡¾Abstract¡¿

The inflammatory bowel disease (IBD) includes  Crohn′s disease and ulcerative colitis. The incidence of IBD is rising on a yearly basis in China, followed by an increased number of patients who suffer from the complications. Medicines and surgical treatment are the major maneuver in the management of patients with IBD. Recently, mesenchymal stromal cells MSCs were found to exert powerful immunomodulatory effects, which suggest the possibility of an alternative treatment for patients with IBD. In this article, the most recent literatures in this field will be reviewed combining with our own clinical experiences.The functions of MSCs, the pathogenesis of IBD and research situation of MSCs therapy for patients with IBD will be discussed.

Author£ºLan Ping,Liu Xuanhui, Wu Xianrui.
Work unit£ºDepartment of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat sen University, Guangzhou 510655, China
DOI£º10.3760/cma.j.issn.1673-9752.2018.09.003

Directory

2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007

Journal Information

Responsible Information

China Association for Science and Technology

Sponsor

Chinese Medical Association

Editing

Editorial Board of Chinese Journal of Digestive Surgery
29 Gaotanyan, Shapingba, Chongqing 400038, China
Tel: 0086-23-68754655
Fax: 0086-23-65317637
Email: digsurg@zhxhwk.com

Editor-in-Chief

DONG Jia-hong

Managing Director

CHEN Min

Publishing

Chinese Medical Journals
Publishing House Co., Ltd.

Overseas Distributor

China International Book Trading Corportation

CSSN

ISSN 1673-9752
CN 11-5610/R